Closing Bell Overtime: Elon Musk Round 2; Zimmer Biomet CEO On Health Care Changes When We Live Longer 5/20/25

Elon Musk returns for unexpected second sit-down with our David Faber. The wide-ranging interview touches on xAI, securing power for AI, the battle for chips supremacy and more.  We have instant takeaways with Walter Isaacson, author of Elon Musk, for a deeper look at the man behind the headlines then Roth Capital’s Craig Irwin breaks down the stock implications for Tesla and the EV space. Plus, market sentiment check with Wells Fargo’s Scott Wren and Payne Capital’s Courtney Garcia and Zimmer Biomet CEO Ivan Tornos from the CNBC CEO Summit.